(3S)-3-(ethylamino)-4-methylpentan-2-one

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (3S)-3-(ethylamino)-4-methylpentan-2-one
• 化学式: C₈H₁₇NO
• 分子量: 143.23
• InChiKey: KFZUKTZUYOOCRV-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• PARATHYROID HORMONE ANALOGS, COMPOSITIONS AND USES THEREOF
  申请人：Danishefsky Samuel J.

  公开号：US20140228293A1

  公开（公告）日：2014-08-14

  The present invention provides parathyroid hormone and/or parathyroid hormone-related protein analogs, compositions thereof and methods thereto.
• LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF
  申请人：PureTech LYT, Inc.

  公开号：US20200390777A1

  公开（公告）日：2020-12-17

  The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, and methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.
• LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS
  申请人：PureTech LYT, Inc.

  公开号：US20220001015A1

  公开（公告）日：2022-01-06

  The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a provided lipid prodrug or a pharmaceutical composition thereof.